Profound Medical (PROF) Income from Continuing Operations (2024 - 2026)
Profound Medical's (PROF) quarterly Income from Continuing Operations came in at 7055000.0 in Q1 2026, up 34.21% year-on-year from 5256570.56 in Q1 2025, and up 13.48% quarter-over-quarter from 8154000.0 in Q4 2025.
Profound Medical (PROF) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Profound Medical's Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 7055000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 34.21% year-over-year to 7055000.0 in Q1 2026; TTM through Mar 2026 was 38895000.0, a 7848.01% decrease from a year earlier, with the FY2025 full-year figure at 42549000.0, down 1016.81% from the prior year.
- Income from Continuing Operations grew to 7055000.0 in Q1 2026 per PROF's latest filing, from 8154000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 27510000.0 in Q4 2024 and bottomed at 15709000.0 in Q2 2025.
- The 3-year median for Income from Continuing Operations is 7977000.0 (2025), against an average of 4997555.56.
- Across the five-year window, Income from Continuing Operations tumbled 129.64% in 2025 and surged 34.21% in 2026, its largest moves.
- Year by year, Income from Continuing Operations stood at 27510000.0 in 2024, then tumbled by 129.64% to 8154000.0 in 2025, then grew by 13.48% to 7055000.0 in 2026.
- Per Business Quant, the three latest PROF Income from Continuing Operations figures stand at 7055000.0 (Q1 2026), 8154000.0 (Q4 2025), and 7977000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.26 Bn | 176.96 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.86 Bn | 99.64 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.53 Bn | 43.86 Bn | 1.29 Bn | 380.70 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.43 Bn | 27.31 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.41 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Profound Medical | 267.15 Mn | 216.86 Mn | 3.83 Mn | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.06 Mn |
| Dec 31, 2025 | -8.15 Mn |
| Sep 30, 2025 | -7.98 Mn |
| Jun 30, 2025 | -15.71 Mn |
| Mar 31, 2025 | -10.72 Mn |
| Dec 31, 2024 | 27.51 Mn |
| Sep 30, 2024 | -9.37 Mn |
| Jun 30, 2024 | -6.92 Mn |
| Mar 31, 2024 | -6.59 Mn |